Poll: How comfortable are you with including biosimilars in your treatment plans?

Poll

Vote in our most recent poll!

How comfortable are you with including biosimilars in your treatment plans?

A. Very excited to begin embracing biosimilars
B. Feeling comfortable exploring biosimilar options, though cautiously
C. Still hesitant, I need to learn more about biosimilars
D. With the knowledge of biosimilars I have, I am not comfortable including this in my treatment plans

RELATED: Introduction to biosimilars for AMD

Recent Videos
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
Jeffry Gerson, OD, FAAO, chats with Optometry Times about his talks about retina conditions at Vision Expo West
Mark Dunbar, OD, FAAO, gives overview of advancements in GA treatment
Mohammad Rafieetary, OD, FAAO
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
© 2025 MJH Life Sciences

All rights reserved.